Inhibition of ovarian cancer growth and implantation by paclitaxel after laparoscopic surgery in a mouse model

Intraoperative intraperitoneal administration of paclitaxel may decrease significantly the occurrence of port-site metastasis and intraperitoneal dissemination in an animal study.